Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma
WEE1 抑制剂 adavosertib (AZD1775) 和伊立替康治疗复发性神经母细胞瘤、髓母细胞瘤和横纹肌肉瘤的儿科 2 期试验
期刊:Cancer
影响因子:6.1
doi:10.1002/cncr.34786
Kristina A Cole, Heba Ijaz, Lea F Surrey, Mariarita Santi, Xiaowei Liu, Charles G Minard, John M Maris, Stephan Voss, Joel M Reid, Elizabeth Fox, Brenda J Weigel